EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

First-line therapy of chronic myeloid leukemia – focus on dasatinib

Philip Amrein

Blood and Lymphatic Cancer: Targets and Therapy · 2012

DOI: 10.2147/blctt.s17930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2012. Verfasst von Philip Amrein. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Amrein, P. (2012). First-line therapy of chronic myeloid leukemia – focus on dasatinib. Blood and Lymphatic Cancer: Targets and Therapy. https://doi.org/10.2147/blctt.s17930

Vancouver

Amrein P. First-line therapy of chronic myeloid leukemia – focus on dasatinib. Blood and Lymphatic Cancer: Targets and Therapy. 2012. doi:10.2147/blctt.s17930

BibTeX
@article{Amrein2012,
  author = {Amrein, Philip},
  title = {First-line therapy of chronic myeloid leukemia – focus on dasatinib},
  journal = {Blood and Lymphatic Cancer: Targets and Therapy},
  year = {2012},
  doi = {10.2147/blctt.s17930}
}
Kostenlos starten →